FDA's newly designated treatment INDs

MeSH terms

• Clinical Protocols
• Cytomegalovirus / immunology
• Cytomegalovirus Infections / therapy*
• Drug Combinations / administration & dosage
• Drug Combinations / therapeutic use
• Drug Therapy, Combination
• Glucuronates / administration & dosage
• Glucuronates / therapeutic use*
• Humans
• Immune Sera / administration & dosage*
• Immunoglobulins*
• Immunoglobulins, Intravenous
• Kidney Transplantation
• Leucovorin / administration & dosage
• Pneumonia, Pneumocystis / drug therapy*
• Quinazolines / administration & dosage
• Quinazolines / therapeutic use*
• Trimetrexate* / analogs & derivatives*
• United States
• United States Food and Drug Administration